Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2015: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2014: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Concerning the management of antithrombotics during periendoscopic period, we revealed the safety of endoscopic biopsy on all kinds of antithrombotics and the safety of high-risk endoscopic procedures on aspirin alone. Additionally, we could start new clinical trials about the feasibilities of high-risk endoscopic procedures on thienopyridines or warfarin considering results obtained from these previous studies.
|